GLP-2 TZ
Dual GIP/GLP-1 receptor agonist · Metabolic / GLP-1 Research
Dual-incretin research peptide, documented lot-by-lot.
GLP-2 TZ is a synthetic dual GIP and GLP-1 receptor agonist studied extensively in metabolic and glucose-regulation models. Supplied as a lyophilized powder for research use only.
Available sizes: 10mg, 30mg, 60mg, 100mg · Form: Lyophilized powder
Documented purity: 99.6% HPLC. Every lot ships with an independent third-party Certificate of Analysis.
How it is studied
- GLP-1 receptor (Incretin) - Agonism at the GLP-1 receptor is studied for its effects on insulinotropic signaling in preclinical models.
- GIP receptor (Incretin) - Concurrent GIP receptor activity distinguishes this dual agonist in comparative receptor studies.
- Energy-balance models (Metabolic) - Investigated in rodent models of energy intake and adiposity. Not a human efficacy claim.
Research Use Only. Not for human or veterinary use.